The Aperlena Verdict
Open raceNo supplier dominates: 66 different companies have won the last 103 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 103 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe contract covers the supply of medicinal products for parenteral administration from the group of TNF alpha inhibitors, namely infliximab and adalimumab. The medicines are intended for the treatment of patients in indications approved under the Summary of Product Characteristics (SmPC) valid on the date of tender submission. The procurement is divided into two lots: one covering infliximab and the other covering adalimumab, both supplied for parenteral administration in line with the approved product information.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 39 minutes ago
More from this buyer
Full buyer profile35 open tenders right now
- Czech Republic - Diagnostics - Supply of diagnostic kits for microorganism identification, including instrument and service 1 day left
- Czech Republic - Antivirals for systemic use - CMV - Letermovir, Maribavir II 1 day left
- Czech Republic - Catheters - Supply of large-size and high-pressure balloon catheters 2 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Medtronic Czechia s.r.o. | 7 | €11.4M | Jul 2026 |
| Alliance Healthcare s.r.o. | 5 | €8.7M | Jul 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 4 | €9.0M | Aug 2026 |
| ADYTON s.r.o., (angl. Ltd, něm. GmbH, franc. S.R.L.A.) | 4 | €3.0M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 3 | €21.1M | May 2026 |
Based on 103 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 104 comparable contracts this buyer awarded in this sector over the last 4 years.
- €264,401
- Lower quartile
- €631,405
- Median award
- €1.7M
- Upper quartile
This tender is estimated 369.3% above that median
Most recent awards
- Česko - Imunosupresiva - Selektivní imunosupresiva - inhibitory Janus kináz II. - Upadacitinib €2,920,849
- Česko - Diagnostika - DG - Dodávka reagencií k multiplexní detekci respiračních patogenů s výpůjčkou přístroje I. €141,873
- Česko - Léčivé přípravky pro zažívací trakt a metabolismus - Inhibitory protonové pumpy - Pantoprazol i.v. aplikace II. €111,075
- Czech Republic - Catheters - Mechanical thrombectomy device including accessories, service and supplies of arterial and venous rotational catheters €383,612
- Česko - Chirurgické implantáty - ZP - KKCH Dodávky sternálních fixačních systémů včetně implantátů a instrumentária €778,041
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€548,450
est. value
1
day left
€1,436,973
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,360,365
- Buyer track record on Aperlena
- 358 notices tracked · 167 awarded
- €288,864,601 in awarded contracts
Never miss a tender like this
161 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert